vimarsana.com
Home
Live Updates
Submit Comments - Breaking News
Pages:
14
15
16
17
18
19
20
Page 13 - Submit Comments News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Post-Warning Letter Meetings Under GDUFA
Post-Warning Letter Meetings Under GDUFA
Guidance issuing office
Program enhancements fiscal years
Office of regulatory affairs
Drug administration
Submit comments
Drug evaluation
Post warning letter meeting
Generic drug user fee amendments
Performance goals
Post warning letter
Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA
Biosmiliars and Procedural
Guidance issuing office
Drug administration
Submit comments
Drug evaluation
Meetings between
Biologics evaluation
Classification Categories for Certain Supplements Under BsUFA III
Classification Categories for Certain Supplements Under BsUFA III
Guidance issuing office
Drug administration
Public health service act
Submit comments
Drug evaluation
Biologics evaluation
Biosimilar user fee amendments
QTc Information in Human Prescription Drug and Biological Product Labeling
QTc Information in Human Prescription Drug and Biological Product Labeling Guidance for Industry
Oncology center
Drug administration
Guidance issuing office
Submit comments
Drug evaluation
Biologics evaluation
Draft Guidance for Industry: Registration and Listing of Cosmetic Product Facilities and Products
This guidance provides recommendations and instructions to assist persons submitting cosmetic product facility registrations and product listings to FDA.
Guidance issuing office
Drug administration
Submit comments
vimarsana © 2020. All Rights Reserved.